Nothing Special   »   [go: up one dir, main page]

DD213216A5 - Verfahren zur herstellung eines neuen pynolidin-derivates - Google Patents

Verfahren zur herstellung eines neuen pynolidin-derivates Download PDF

Info

Publication number
DD213216A5
DD213216A5 DD83257518A DD25751883A DD213216A5 DD 213216 A5 DD213216 A5 DD 213216A5 DD 83257518 A DD83257518 A DD 83257518A DD 25751883 A DD25751883 A DD 25751883A DD 213216 A5 DD213216 A5 DD 213216A5
Authority
DD
German Democratic Republic
Prior art keywords
temperature
product
alkyl
general formula
radical
Prior art date
Application number
DD83257518A
Other languages
German (de)
English (en)
Inventor
Jean-Louis Fabre
Daniel Farge
Claude James
Daniel Lave
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of DD213216A5 publication Critical patent/DD213216A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
DD83257518A 1982-12-07 1983-12-05 Verfahren zur herstellung eines neuen pynolidin-derivates DD213216A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8220492A FR2537133A1 (fr) 1982-12-07 1982-12-07 Nouveaux derives de la (piperazinyl-1)-5 pyrrolidine, leur preparation et les medicaments qui les contiennent

Publications (1)

Publication Number Publication Date
DD213216A5 true DD213216A5 (de) 1984-09-05

Family

ID=9279863

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83257518A DD213216A5 (de) 1982-12-07 1983-12-05 Verfahren zur herstellung eines neuen pynolidin-derivates

Country Status (25)

Country Link
US (1) US4547504A (es)
EP (1) EP0110795B1 (es)
JP (1) JPS59110670A (es)
AT (1) ATE18548T1 (es)
AU (1) AU560075B2 (es)
BG (1) BG40808A3 (es)
CA (1) CA1208645A (es)
CS (1) CS240982B2 (es)
DD (1) DD213216A5 (es)
DE (1) DE3362566D1 (es)
DK (1) DK562783A (es)
ES (1) ES8406436A1 (es)
FI (1) FI76320C (es)
FR (1) FR2537133A1 (es)
GR (1) GR72855B (es)
HU (1) HU191903B (es)
IE (1) IE56453B1 (es)
IL (1) IL70396A (es)
MA (1) MA19966A1 (es)
NO (1) NO158218C (es)
NZ (1) NZ206498A (es)
PL (1) PL141385B1 (es)
PT (1) PT77774B (es)
SU (1) SU1240359A3 (es)
ZA (1) ZA839070B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA871335B (en) * 1986-02-27 1987-09-30 Duphar Int Res New aryl-substituted(n-piperidinyl)methyl-and(n-piperazinyl)-methylazoles having antipsychotic properties
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
US6897213B1 (en) 1995-11-21 2005-05-24 Warner-Lambert Company Heterocycles as cholecystokinin (CCK) ligands
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247549A (en) * 1978-12-27 1981-01-27 Ici Americas Inc. Piperazine-1-carboxylic acid esters possessing antidepressant or analgesic activity

Also Published As

Publication number Publication date
US4547504A (en) 1985-10-15
BG40808A3 (en) 1987-02-16
FI834453A0 (fi) 1983-12-05
IL70396A (en) 1986-11-30
ATE18548T1 (de) 1986-03-15
CA1208645A (fr) 1986-07-29
ZA839070B (en) 1984-07-25
IE56453B1 (en) 1991-08-14
PL244921A1 (en) 1985-03-26
SU1240359A3 (ru) 1986-06-23
AU2210883A (en) 1984-06-14
HU191903B (en) 1987-04-28
PT77774A (fr) 1984-01-01
PL141385B1 (en) 1987-07-31
ES527897A0 (es) 1984-08-01
FR2537133A1 (fr) 1984-06-08
EP0110795B1 (fr) 1986-03-12
FI76320C (fi) 1988-10-10
DE3362566D1 (en) 1986-04-17
FI76320B (fi) 1988-06-30
CS904183A2 (en) 1985-06-13
IE832867L (en) 1984-06-07
DK562783A (da) 1984-06-08
MA19966A1 (fr) 1984-07-01
GR72855B (es) 1983-12-08
CS240982B2 (en) 1986-03-13
JPS59110670A (ja) 1984-06-26
EP0110795A1 (fr) 1984-06-13
PT77774B (fr) 1986-07-11
DK562783D0 (da) 1983-12-06
IL70396A0 (en) 1984-03-30
AU560075B2 (en) 1987-03-26
NO158218B (no) 1988-04-25
NO158218C (no) 1988-08-03
NZ206498A (en) 1986-05-09
FR2537133B1 (es) 1985-05-17
NO834481L (no) 1984-06-08
ES8406436A1 (es) 1984-08-01
FI834453A (fi) 1984-06-08

Similar Documents

Publication Publication Date Title
DE3687288T2 (de) Chinuclidinderivate.
DE69722858T2 (de) Intimale verdickungsinhibitoren
DE69208551T2 (de) Benzo(a)fluorenverbindungen
DE69120899T2 (de) Neue N-Benzoylprolin-Derivate, Verfahren zur Herstellung und diese enthaltende Arzneimittel
DE60307875T2 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusamensetzungen
DD263772A5 (de) Verfahren zur herstellung neuer 1h, 3h-pyrrolo[1,2-c]thiazolderivate
EP0192056B1 (de) Verfahren zur Herstellung von Labdan-Derivaten und ihre Verwendung als Arzneimittel
CH637956A5 (de) In 11-stellung substituierte 5,11-dihydro-6h-pyrido-(2,3-b)(1,4)benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE68925270T2 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
EP0089028B1 (de) Neue Theophyllin-Derivate und Verfahren zu ihrer Herstellung
DD297822A5 (de) Neue 1h, 3h-pyrrol(1,2-c)thiazolcarboxamid-7-derivate, ihre herstellung und sie enthaltende pharmazeutische verbindungen
DD240205A5 (de) Substituierte benzylphthalazinon-derivate
DE3788195T2 (de) DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
DE4430091A1 (de) Verwendung von N-substituierten Phenothiazinen
DE69718968T2 (de) 3-(bis-substituierte-phenylmethylen)oxindol-derivate
EP0152868B1 (de) Isoxazol-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69014930T2 (de) Aralkylamin-Verbindungen.
DD213216A5 (de) Verfahren zur herstellung eines neuen pynolidin-derivates
DD210051A5 (de) Verfahren zur darstellung eines neuen thienopyridinon-derivats
DD202563A5 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen
DE3804936A1 (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
EP0085893B1 (de) Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2734270C2 (es)
DE69230110T2 (de) An drei ringen substituierte tetrahydropyridin-derivate
CH630058A5 (de) Verfahren zur herstellung von neuen disubstituierten phenolaethern des 3-amino-2-hydroxypropans.